MacroGenics Announces MGC018 Publication in Molecular Cancer Therapeutics
23 sept. 2020 07h15 HE
|
MacroGenics, Inc.
Manuscript describes preclinical development of MGC018Phase 1 dose expansion trial evaluating MGC018 in patients with mCRPC, TNBC and NSCLC is currently recruiting patients ROCKVILLE, MD,...